Vaporox

The new standard in wound care.

Vaporous Hyperoxia Therapy (VHT™)

VHT-100

Vaporous Hyperoxia Therapy (VHT™) is a patented, 510(k) cleared technology that is clinically validated as a safe and effective treatment for diabetic foot ulcers (DFUs). VHT™ provides a unique system for delivering a combination of elements that have been shown to accelerate healing of DFUs.

Vaporox currently provides VHT™ in the Dallas, Denver and Phoenix markets with the VHT-100.

What is VHT™?

  • Patented wound healing technology
  • Clinically validated as safe and effective
  • Treats DFUs, VLUs, post-surgical wounds and many more
  • The hydrating vapor gently surrounds the wound and the elements are passively absorbed through the cell walls
  • 1-hour treatment, two to three times per week 
  • Painless and soothing 
  • Performed along with standard wound care
  • Delivered in the doctor’s office
Pending 510(K), not available for sale within the United States
Pending 510(K), not available for sale within the United States

VHT-200

Vaporox has designed its next-generation (VHT-200) device and submitted a 510(k) to the FDA. Clearance is anticipated soon.